Adimmune Corporation (TPE:4142)
Taiwan · Delayed Price · Currency is TWD 17.80
-0.15 (-0.84%)
May 8, 2026, 1:30 PM CST
Adimmune Market Cap
Adimmune has a market cap or net worth of 7.5 billion as of May 8, 2026.
Market Cap
7.50B
Enterprise Value
8.22B
Revenue
1.40B
Ranking
n/a
PE Ratio
n/a
Stock Price
17.80
Market Cap Chart
Since September 29, 2010, Adimmune's market cap has decreased from 11.10B to 7.50B, a decrease of -32.39%. That is a compound annual growth rate of -2.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 7.50B | -6.07% |
| Dec 31, 2025 | 7.99B | -5.72% |
| Dec 31, 2024 | 8.47B | -39.37% |
| Dec 29, 2023 | 13.97B | -7.97% |
| Dec 30, 2022 | 15.18B | -20.83% |
| Dec 30, 2021 | 19.18B | -20.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tanvex BioPharma | 10.41B |
| PharmaEngine | 8.30B |
| Gongwin Biopharm Holdings | 7.73B |
| Acepodia | 7.42B |
| TaiGen Biopharmaceuticals Holdings | 6.73B |
| Mycenax Biotech | 5.92B |
| Sinphar Pharmaceutical | 5.83B |
| Savior Lifetec | 5.82B |